TLX
Telix Pharmaceuticals Limited
NASDAQ · Healthcare · Biotechnology · AU
$11.92
+1.53%Margins
Gross margin
54.3%
EBITDA margin
5.5%
EBIT margin
3.0%
Net margin
3.3%
FCF margin
-3.0%
11.8%
Return on equity
4.2%
Return on assets
4.8%
Return on invested capital
1.34x
Asset turnover
$8.4M
Cash from operations
$0.77
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026